Ian Gillies Sr. finds it too difficult to revisit the photographs he captured during his son’s hospital stay at the Health Sciences Centre in St. John’s. Recalling the ordeal is enough for him as he focuses on moving forward. “We’ve been through a lot, and it really alters your perspective,” he shared.
The challenging journey began in the summer of 2023 when Ian Gillies Jr., a recent graduate of the College of North Atlantic, started feeling unusually fatigued despite being a 22-year-old. His energy levels were low, and he struggled to climb stairs in the house he shared with his father in Conception Bay South.
As time passed, Gillies Jr.’s condition worsened, leading to a point where he had to be taken to the doctor in a wheelchair, as recounted by Gillies Sr. Alongside experiencing constipation and bloating, Gillies Jr. sought relief in their hot tub, using it as a warm compress to alleviate the discomfort.
The turning point came in October when their family doctor advised an immediate visit to the emergency room upon receiving new test results. By then, Gillies Jr. had gained almost 60 pounds in a month due to fluid retention in his body.
Medical professionals ruled out common causes like cancers, infections, and autoimmune disorders. They drained significant amounts of accumulated fluid around Gillies Jr.’s abdomen and worked tirelessly to address his deteriorating health condition. Despite the intensive care, Gillies Jr. has minimal recollection of those days spent confined to his hospital bed.
A breakthrough occurred when first-year internal medicine resident Dr. Steven Rowe joined the medical team and identified a rare subtype of Castleman disease known as TAFRO syndrome. This discovery was pivotal in diagnosing Gillies Jr.’s condition correctly, marking the first recognized case of TAFRO in Newfoundland and Labrador.
Following the diagnosis, Gillies Jr. responded positively to a new treatment involving the drug siltuximab, administered intravenously. While the new normal brought about disruptions to his routine, Gillies Jr. expressed gratitude for being asymptomatic and healthy, emphasizing the relief of having the illness under control.
The successful outcome prompted the family and medical professionals to raise awareness about Castleman and TAFRO diseases to expedite future diagnoses. Dr. Rowe’s collaborative efforts led to a significant study published in a renowned medical journal, shedding light on a simpler and quicker method of distinguishing between TAFRO syndrome and related diseases.
The research findings have the potential to revolutionize the diagnostic process for rare diseases like TAFRO, offering hope for prompt and effective treatment. Dr. Rowe’s dedication to investigating rare conditions and his impactful contribution to medical research underscore the importance of proactive healthcare initiatives for improved patient outcomes.